Peripheral Arterial Disease and Plaque

Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment

DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs.

Peripheral Arterial Disease

Peripheral Arterial Disease Ultrasound Angioplasty Plaque

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease

Peripheral Arterial Disease Exercise Ischemia Quality of Life

How much do you know about PAD (Peripheral Artery Disease)?

CTVS

MAY 29, 2024

Nearly 10 million Americans suffer from the circulatory condition Peripheral Artery Disease, or PAD. PAD occurs when plaque builds up in the arteries and limits blood flow to the lower extremities.

Peripheral Arterial Disease

Peripheral Arterial Disease Plaque Circulation

How to Prevent Peripheral Artery Disease

AMS Cardiology

NOVEMBER 4, 2023

However, when these arteries become narrowed or blocked conditions like Peripheral Artery Disease (PAD) can emerge, posing a threat to our overall health. Understanding Peripheral Artery Disease Peripheral artery disease or PAD is a condition in which plaque builds up in the arteries that lead to the legs and feet.

Peripheral Arterial Disease

Peripheral Arterial Disease Blood Pressure Diet Exercise

Revascularization enhances quality of life for patients with chronic limb threatening ischemia

Science Daily - Heart Disease

APRIL 10, 2024

Over 200 million people around the world experience peripheral artery disease (PAD) -- a condition caused by the narrowing of the blood vessels from the heart to the lower limbs that leads to pain when walking -- and for roughly 1-in-10 this advances to chronic limb-threatening ischemia (CLTI), an advanced form of PAD.

Quality of Life

Quality of Life Ischemia Peripheral Arterial Disease Plaque

PAD Pulse Alliance Urges Screening During American Heart Month

DAIC

FEBRUARY 4, 2025

3, 2025 Today, Peripheral Artery Disease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. Peripheral Artery Disease (PAD) is a chronic condition where plaquea sticky substance made of fat and cholesterolbuilds up in the arteries that carry blood to your legs.

Peripheral Arterial Disease

Peripheral Arterial Disease Risk Factors Blood Pressure Diabetes

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

DAIC

JUNE 4, 2024

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck.

Stents

Stents Stent Research Stroke

PAD Awareness Month and Treating Arterial Ulcers

CTVS

SEPTEMBER 17, 2024

It is estimated that more than 10 million Americans are living with PAD, or Peripheral Artery Disease. PAD is a serious condition affecting circulation and blood vessels, causing them to narrow from plaque buildup in the arteries and blocking blood flow to the extremities, typically the legs and feet.

Peripheral Arterial Disease

Peripheral Arterial Disease Atherosclerosis Plaque Cholesterol

Philips Enrolls First Patient in Clinical Trial for Integrated Single-Device to Treat PAD

DAIC

NOVEMBER 8, 2024

The goal of this pivotal study is to evaluate the safety and efficacy of using this device that integrates laser atherectomy and intravascular lithotripsy in a single device to treat complex, calcified lesions in a single procedure for patients with peripheral artery disease (PAD), restoring blood flow to their legs.

Innovation

Innovation Peripheral Arterial Disease Technology Ultrasound

Scientists find cancer-like features in atherosclerosis, spurring opportunity for new treatment approaches

Science Daily - Heart Disease

APRIL 30, 2024

Atherosclerosis is characterized by a narrowing of arterial walls and can increase risk of coronary artery disease, stroke, peripheral artery disease, or kidney disorders.

Atherosclerosis

Atherosclerosis Cancer Peripheral Arterial Disease Coronary Artery Disease

Minimally Invasive Vascular Disease Treatments

CTVS

OCTOBER 30, 2024

Vascular disease affects the body’s vast network of blood vessels, veins and arteries. Common examples of vascular disease are aneurysms (a dangerous bulge in an artery wall), atherosclerosis (plaque buildup in the… Source

Aneurysm

Aneurysm Atherosclerosis Plaque Heart Disease

Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

DAIC

JUNE 18, 2024

The breakthrough designation, according to the Milpitas, CA-based technology company, is for an indication to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. of the U.S.

Coronary Artery Disease

Coronary Artery Disease Technology Stents Stent

SCAI, SIR, and SVS Jointly Publish Proceedings from Multispecialty Peripheral IVUS Roundtable

DAIC

JANUARY 9, 2024

"The roundtable provided a unique opportunity to identify knowledge gaps and discuss how IVUS can enhance our understanding and treatment of peripheral arterial and deep venous pathology." IVUS is a minimally invasive imaging technique that allows physicians to visualize the inside of blood vessels in real-time.

Peripheral Arterial Disease

Peripheral Arterial Disease Ultrasound Angioplasty Interventional Cardiology

Clinical utility of lipoprotein(a): an interventionist’s perspective

The British Journal of Cardiology

AUGUST 1, 2024

Large-scale observational data have demonstrated a robust, independent association of elevated lipoprotein(a) (Lp[a]) levels with atherosclerotic cardiovascular disease (CVD), stroke, and peripheral artery disease.

Peripheral Arterial Disease

Peripheral Arterial Disease Myocardial Infarction Plaque Cardiovascular Disease

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

DAIC

MAY 8, 2024

The 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS).” “Diagnosis and treatment of ischemia-producing coronary stenoses improves 5-year survival of patients undergoing major vascular surgery.” 2024, [link].

Coronary Artery Disease

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction

Two Studies Show Clot-Sensing Guidewire Successfully Identifies 'Fresh Clot' to Support Decision-Making in PAD Treatment

DAIC

DECEMBER 16, 2024

13, 2024Sensome hasannounced positive results from two studies of its Clotild Smart Guidewire System demonstrating its ability to successfully identify fresh clot thrombus rich in red blood cells (RBCs) in peripheral artery disease (PAD) and differentiate it from other tissue encountered during PAD procedures. Lancet Glob.

Peripheral Arterial Disease

Peripheral Arterial Disease Technology Plaque Stroke

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 4 In the U.S.

Cardiovascular Disease

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease

Abstract 114: “Failing” DAPT? Think Again

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

However, CTA head and neck 4 days later demonstrated 90 percent stenosis of the mid left V2 at the C3‐4 level and a 75‐90 percent stenosis of the left mid V2 segment at the C5‐6 level (hard and soft plaque in these areas). He was switched from DAPT to aspirin and warfarin because he was considered a “DAPT failure.”

Stenosis

Stenosis Peripheral Arterial Disease Pacemaker Atherosclerosis

Cardiovascular Update

Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

How much do you know about PAD (Peripheral Artery Disease)?

How to Prevent Peripheral Artery Disease

Revascularization enhances quality of life for patients with chronic limb threatening ischemia

PAD Pulse Alliance Urges Screening During American Heart Month

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

PAD Awareness Month and Treating Arterial Ulcers

Philips Enrolls First Patient in Clinical Trial for Integrated Single-Device to Treat PAD

Scientists find cancer-like features in atherosclerosis, spurring opportunity for new treatment approaches

Minimally Invasive Vascular Disease Treatments

Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

SCAI, SIR, and SVS Jointly Publish Proceedings from Multispecialty Peripheral IVUS Roundtable

Clinical utility of lipoprotein(a): an interventionist’s perspective

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

Two Studies Show Clot-Sensing Guidewire Successfully Identifies 'Fresh Clot' to Support Decision-Making in PAD Treatment

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

Abstract 114: “Failing” DAPT? Think Again

Stay Connected